HealthEquity, Inc. (NASDAQ:HQY)‘s stock had its “hold” rating reiterated by equities researchers at Robert W. Baird in a report released on Thursday.

Several other equities analysts have also recently commented on the company. BidaskClub upgraded HealthEquity from a “strong sell” rating to a “sell” rating in a research note on Friday, September 15th. Oppenheimer Holdings, Inc. reiterated a “buy” rating and set a $61.00 target price on shares of HealthEquity in a research note on Wednesday, September 6th. Cantor Fitzgerald reiterated a “buy” rating and set a $56.00 target price on shares of HealthEquity in a research note on Tuesday, September 5th. Zacks Investment Research cut HealthEquity from a “buy” rating to a “hold” rating in a research note on Friday, August 4th. Finally, TheStreet upgraded HealthEquity from a “c” rating to a “b” rating in a research note on Monday, July 31st. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and eight have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $56.50.

Shares of HealthEquity (HQY) opened at 47.35 on Thursday. The firm has a market cap of $2.86 billion, a PE ratio of 70.25 and a beta of 1.75. The firm’s 50-day moving average is $44.62 and its 200-day moving average is $46.01. HealthEquity has a 12-month low of $30.34 and a 12-month high of $54.95.

HealthEquity (NASDAQ:HQY) last released its earnings results on Tuesday, September 5th. The company reported $0.27 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.14 by $0.13. The company had revenue of $56.90 million during the quarter, compared to analysts’ expectations of $55.66 million. HealthEquity had a return on equity of 13.93% and a net margin of 20.27%. The business’s revenue was up 28.7% on a year-over-year basis. During the same period in the prior year, the business posted $0.16 EPS. Equities analysts expect that HealthEquity will post $0.71 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “HealthEquity, Inc. (HQY) Stock Rating Reaffirmed by Robert W. Baird” was published by Daily Political and is the property of of Daily Political. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark & copyright law. The correct version of this story can be read at https://www.dailypolitical.com/2017/09/22/healthequity-inc-hqy-stock-rating-reaffirmed-by-robert-w-baird.html.

In related news, VP Ashley Dreier sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, September 6th. The stock was sold at an average price of $45.50, for a total transaction of $455,000.00. Following the sale, the vice president now directly owns 15,652 shares of the company’s stock, valued at approximately $712,166. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Stephen Neeleman sold 8,500 shares of the company’s stock in a transaction that occurred on Monday, July 17th. The shares were sold at an average price of $50.83, for a total value of $432,055.00. Following the sale, the insider now directly owns 1,000 shares in the company, valued at $50,830. The disclosure for this sale can be found here. Over the last three months, insiders have sold 1,630,567 shares of company stock worth $82,623,514. Corporate insiders own 29.00% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the business. Vanguard Group Inc. increased its position in HealthEquity by 6.2% in the first quarter. Vanguard Group Inc. now owns 4,115,237 shares of the company’s stock worth $174,691,000 after buying an additional 240,136 shares during the period. Paloma Partners Management Co acquired a new stake in HealthEquity in the first quarter worth $503,000. First Trust Advisors LP increased its position in HealthEquity by 17.0% in the second quarter. First Trust Advisors LP now owns 94,283 shares of the company’s stock worth $4,698,000 after buying an additional 13,676 shares during the period. Royce & Associates LP increased its position in HealthEquity by 18.0% in the second quarter. Royce & Associates LP now owns 139,200 shares of the company’s stock worth $6,936,000 after buying an additional 21,200 shares during the period. Finally, Teacher Retirement System of Texas acquired a new stake in HealthEquity in the second quarter worth $200,000. 90.97% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Analyst Recommendations for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.